Condition
Recurrent High Grade Glioma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Recurrent High Grade Glioma clinical trials that are recruiting, at sites in 2 countries (most in United States (3), China (2)). By phase: Phase 1 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest Recurrent High Grade Glioma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Dual-target CAR-NK cell therapy for recurrent glioblastoma and high-grade glioma | Phase 1 | Shenzhen, Guangdong | Recruiting | Mar 18, 2026 |
| New immunotherapy for treating brain tumors in children and young adults | Phase 1 | Minneapolis, Minnesota | Recruiting | Mar 12, 2024 |
| Laser treatment for recurrent high-grade glioma | — | Beijing, Beijing Municipality and 8 other locations | Recruiting | Dec 8, 2023 |
| Evaluating a new oncolytic virus treatment for recurrent high-grade glioma | Phase 1 | New York, New York and 1 other locations | Recruiting | Nov 13, 2023 |
| Combining Temozolomide with Abexinostat for Recurrent Glioma Treatment | Phase 1 | Omaha, Nebraska | Recruiting | Jan 26, 2023 |
All recruiting trials (5)
-
Dual-target CAR-NK cell therapy for recurrent glioblastoma and high-grade glioma
This phase 1 study will test whether injecting dual-target CAR-NK cells into the brain is safe and can help adults with recurrent or progressive glioblastoma or other high-grade gliomas.
-
New immunotherapy for treating brain tumors in children and young adults
This study is testing a new immunotherapy treatment for children and young adults with aggressive brain tumors to see if it can help their immune system fight the cancer better.
-
Laser treatment for recurrent high-grade glioma
This study tests if a new laser treatment can help people with recurrent high-grade glioma live longer without their cancer getting worse compared to standard treatments.
-
Evaluating a new oncolytic virus treatment for recurrent high-grade glioma
This study is testing a new virus treatment for people with recurrent high-grade glioma to see if it is safe and can help improve their condition.
-
Combining Temozolomide with Abexinostat for Recurrent Glioma Treatment
This study is testing a new combination of two drugs, Temozolomide and Abexinostat, to see if it can help people with recurrent high-grade gliomas like glioblastoma feel better and manage their condition.
Related topics
Quick answers
How many Recurrent High Grade Glioma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (3 trials), China (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 4. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.